Dive Insight: The BIA hopes U.K.'s biotech sector can become "the third global biotech cluster" in the world, after Cambridge and San Francisco. The U.K. already is leading the biotech industry in Europe, but still has a ways to go to come close to markets in the U.S.
Last year, one-third of all venture capital funds raised were in the U.K. and British companies accounted for 27% of all money raised from European biotechnology company IPOs in 2015, according to the BIA.
